Patent · US Active

Orlistat compositions

US8071571B2 · kind B2 · utility

0Cited by
19References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 20, 2010
Grant dateDec 6, 2011
Priority date—
Expiry dateApr 20, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical combination or composition containing a lipase inhibitor, preferably orlistat, and a bile acid sequestrant is useful for treating obesity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.